Sponsors (9)
The bill increases transparency, timeliness, and evidence standards for vaccine recommendations and injury compensation—strengthening public confidence and procedural consistency—but it also restricts agency flexibility and raises evidentiary and procedural barriers that could slow safety responses, adoption of novel vaccines, and compensation decisions.
Children, clinicians, and the public will get clearer, more transparent, and more timely CDC/ACIP vaccine recommendations because recommendations must be published and ACIP procedures and records are codified.
People receiving care and health systems will get faster guidance on newly licensed vaccines and breakthrough therapies due to shorter review timelines for the advisory committee.
Vaccine recipients gain stronger protections because removals from or changes to the Vaccine Injury Table require a preponderance of the best available scientific evidence, making compensable-injury decisions more evidence‑based.
Patients and health systems may be harmed if the CDC loses flexibility during emergencies because the bill requires ACIP recommendations be adopted unless the CDC Director documents contrary evidence, constraining rapid, situation-specific responses.
Tight statutory deadlines for ACIP action (e.g., 90 days) could pressure the committee to issue guidance based on limited post‑licensure data, risking premature or less‑robust recommendations.
Requiring a preponderance of peer‑reviewed evidence to change the Vaccine Injury Table or adopt recommendations may slow updates to guidance and compensation eligibility, delaying responses to emerging safety signals and slowing availability of novel vaccines where peer‑reviewed literature is limited.
Based on analysis of 3 sections of legislative text.
Codifies ACIP with evidence‑based rules and timelines and requires a preponderance of peer‑reviewed evidence to remove or modify Vaccine Injury Table entries.
Codifies the federal Advisory Committee on Immunization Practices (ACIP) into statute and subjects it to most Federal advisory committee rules; requires ACIP recommendations to be based on a preponderance of the best available peer‑reviewed scientific evidence and sets procedures for how the CDC Director must review, publish, and act on those recommendations. It also raises the evidentiary standard for removing or changing entries on the Vaccine Injury Table, requiring a preponderance of the best available scientific evidence to support removals or other modifications while leaving the Secretary’s authority to add new vaccines intact. The bill adds timelines and transparency requirements for consideration of newly licensed vaccines, breakthrough therapies, and vaccines tied to declared public health emergencies, and requires prompt reporting to Congress when the CDC Director declines to adopt ACIP recommendations.
Introduced December 3, 2025 by John Wright Hickenlooper · Last progress December 3, 2025